Glutaredoxin 1 Protects Dopaminergic Cells by Increased Protein Glutathionylation in Experimental Parkinson's Disease

Antioxidants and Redox Signaling - United States
doi 10.1089/ars.2011.4474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Glutaredoxin Regulates Vascular Development by Reversible Glutathionylation of Sirtuin 1

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Β3-Adrenoceptor Agonist Protects Dopaminergic Neurons in the 6-Hydroxydopamine Model of Parkinson's Disease.

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Continuous Dopaminergic Stimulation in Parkinson's Disease

Canadian Journal of Neurological Sciences
MedicineNeurology
1987English

Induction of mPGES-1 in Dopaminergic Neurons Contributes to Neurodegeneration in Parkinson's Disease

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2019English

Increased Glutathione S-Transferase Activity Rescues Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Failure of a Peripheral Dopaminergic Marker in Parkinson's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1983English

Increased Energy Expenditure in Parkinson's Disease.

BMJ
1990English

Mitochondria-Mediated Damage to Dopaminergic Neurons in Parkinson's Disease (Review)

International Journal of Molecular Medicine
MedicineGenetics
2017English

Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy